Literature DB >> 8314167

Silymarine during maintenance therapy of acute promyelocytic leukemia.

R Invernizzi, S Bernuzzi, D Ciani, E Ascari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8314167

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  9 in total

Review 1.  Herbal therapy use by cancer patients: a literature review on case reports.

Authors:  Oluwadamilola Olaku; Jeffrey D White
Journal:  Eur J Cancer       Date:  2010-12-23       Impact factor: 9.162

2.  Silymarin and its active component silibinin act as novel therapeutic alternatives for salivary gland cancer by targeting the ERK1/2-Bim signaling cascade.

Authors:  Eun-Sun Choi; Sejun Oh; Boonsil Jang; Hyun-Ju Yu; Ji-Ae Shin; Nam-Pyo Cho; In-Hyoung Yang; Dong-Hoon Won; Hye-Jeong Kwon; Seong Doo Hong; Sung-Dae Cho
Journal:  Cell Oncol (Dordr)       Date:  2017-04-11       Impact factor: 6.730

Review 3.  The use of silymarin in the treatment of liver diseases.

Authors:  R Saller; R Meier; R Brignoli
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 4.  Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions.

Authors:  Tomas Koltai; Larry Fliegel
Journal:  J Evid Based Integr Med       Date:  2022 Jan-Dec

5.  A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL).

Authors:  Elena J Ladas; David J Kroll; Nicholas H Oberlies; Bin Cheng; Deborah H Ndao; Susan R Rheingold; Kara M Kelly
Journal:  Cancer       Date:  2010-01-15       Impact factor: 6.860

Review 6.  Multitargeted therapy of cancer by silymarin.

Authors:  Kumaraguruparan Ramasamy; Rajesh Agarwal
Journal:  Cancer Lett       Date:  2008-05-09       Impact factor: 8.679

7.  Thiopurines induce oxidative stress in T-lymphocytes: a proteomic approach.

Authors:  Misbah Misdaq; Sonia Ziegler; Nicolas von Ahsen; Michael Oellerich; Abdul R Asif
Journal:  Mediators Inflamm       Date:  2015-03-22       Impact factor: 4.711

Review 8.  Silymarin and Cancer: A Dual Strategy in Both in Chemoprevention and Chemosensitivity.

Authors:  Dominique Delmas; Jianbo Xiao; Anne Vejux; Virginie Aires
Journal:  Molecules       Date:  2020-04-25       Impact factor: 4.411

Review 9.  Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer.

Authors:  Maryam Fallah; Amirhossein Davoodvandi; Shahin Nikmanzar; Sarehnaz Aghili; Seyed Mohammad Ali Mirazimi; Michael Aschner; Amir Rashidian; Michael R Hamblin; Mohsen Chamanara; Navid Naghsh; Hamed Mirzaei
Journal:  Biomed Pharmacother       Date:  2021-08-13       Impact factor: 6.529
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.